Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Gross Margin (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Gross Margin for 5 consecutive years, with 370.14% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Margin rose 61622.0% year-over-year to 370.14%, compared with a TTM value of 112.64% through Sep 2025, up 41531.0%, and an annual FY2024 reading of 65.09%, up 51052.0% over the prior year.
  • Gross Margin was 370.14% for Q3 2025 at Lucid Diagnostics, up from 461.05% in the prior quarter.
  • Across five years, Gross Margin topped out at 565.68% in Q4 2024 and bottomed at 874.21% in Q2 2023.
  • Average Gross Margin over 5 years is 159.21%, with a median of 246.08% recorded in 2024.
  • The sharpest move saw Gross Margin tumbled -75331bps in 2023, then surged 88953bps in 2024.
  • Year by year, Gross Margin stood at 100.0% in 2021, then surged by 329bps to 429.46% in 2022, then tumbled by -175bps to 323.85% in 2023, then soared by 275bps to 565.68% in 2024, then crashed by -35bps to 370.14% in 2025.
  • Business Quant data shows Gross Margin for LUCD at 370.14% in Q3 2025, 461.05% in Q2 2025, and 87.32% in Q1 2025.